<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">FOSFOMYCIN TROMETHAMINE</span><br/>(fos-fo-my'sin)<br/><span class="topboxtradename">Monurol<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span><br/><b>Prototype: </b>Nitrofurantoin<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>3 g packets</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic, broad-spectrum, bactericidal antibiotic active against gram-negative and gram-positive aerobic organisms that blocks
         the first steps in bacterial cell wall synthesis.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Acts as a bactericidal against <i>Enterococcus faecalis, E. faecium,</i> and <i>Escherichia coli</i>. In addition, it is effective against <i>Klebsiella, Proteus,</i> and <i>Serratia.</i> Indicated by improvement in cystitis symptoms within 23 d.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of uncomplicated UTIs in women due to susceptible strains of <i>E. coli</i> and <i>E. faecalis.</i>
</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to fosfomycin; lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Pregnancy (category B). Safety and efficiency in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">UTI</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 3 g sachet dissolved in 34 oz of water as a single dose given once<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Pour entire contents of a single dose into 34 oz water (not hot), stir to dissolve completely, and give immediately.
            Drug must not be taken in the dry form.
         </li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Pain. <span class="typehead">CNS:</span> <span class="speceff-common">Headache,</span> dizziness. <span class="typehead">GI:</span> <span class="speceff-common">Diarrhea,</span> nausea, abdominal pain, dyspepsia. <span class="typehead">Respiratory:</span> Rhinitis, pharyngitis. <span class="typehead">Urogenital:</span> Vaginitis, dysmenorrhea. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Metoclopramide</b> may decrease urinary excretion of fosfomycin. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract, 37% of dose reaches systemic circulation as free acid. <span class="typehead">Peak Urine Concentration:</span> 24 h. <span class="typehead">Distribution:</span> Not protein bound, distributed to kidneys, bladder wall, prostate, and seminal vesicles. <span class="typehead">Elimination:</span> Primarily excreted in urine. <span class="typehead">Half-Life:</span> 5.7 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Obtain urine C&amp;S before and after therapy.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Notify physician if symptoms do not improve in 23 d.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>